{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:37:22Z","timestamp":1791265042163,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T00:00:00Z","timestamp":1268611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T00:00:00Z","timestamp":1268611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,5,20]]},"DOI":"10.1038\/onc.2010.67","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T07:19:17Z","timestamp":1268637557000},"page":"2962-2972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":168,"title":["Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1\u03b1-induced metabolic reprograming"],"prefix":"10.1038","volume":"29","author":[{"given":"F","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T V","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R","family":"Swider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P V","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J V","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C B","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,15]]},"reference":[{"key":"BFonc201067_CR1","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-0076","volume":"65","author":"DJ Barnes","year":"2005","unstructured":"Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A et al. (2005a). Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia. Cancer Res 65: 8912\u20138919.","journal-title":"Cancer Res"},{"key":"BFonc201067_CR2","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","volume":"24","author":"K Barnes","year":"2005","unstructured":"Barnes K, McIntosh E, Whetton AD, Daley GQ, Bentley J, Baldwin SA . (2005b). Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. Oncogene 24: 3257\u20133267.","journal-title":"Oncogene"},{"key":"BFonc201067_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/bse0430017","volume":"43","author":"EL Bell","year":"2007","unstructured":"Bell EL, Chandel NS . (2007). Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem 43: 17\u201327.","journal-title":"Essays Biochem"},{"key":"BFonc201067_CR4","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1182\/blood.V90.12.4947","volume":"90","author":"M Carroll","year":"1997","unstructured":"Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB et al. (1997). CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood 90: 4947\u20134952.","journal-title":"Blood"},{"issue":"Pt 4","key":"BFonc201067_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/000456329603300413","volume":"33","author":"BR Chamberlain","year":"1996","unstructured":"Chamberlain BR, Buttery JE, Pannall PR . (1996). A stable reagent mixture for the whole blood transketolase assay. Ann Clin Biochem 33 (Pt 4): 352\u2013354.","journal-title":"Ann Clin Biochem"},{"key":"BFonc201067_CR6","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger M, Buchdunger E, Druker BJ . (2005). The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105: 2640\u20132653.","journal-title":"Blood"},{"key":"BFonc201067_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1440-1711.2004.01296.x","volume":"83","author":"AL Dewar","year":"2005","unstructured":"Dewar AL, Doherty KV, Hughes TP, Lyons AB . (2005). Imatinib inhibits the functional capacity of cultured human monocytes. Immunol Cell Biol 83: 48\u201356.","journal-title":"Immunol Cell Biol"},{"key":"BFonc201067_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. (1996). Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2: 561\u2013566.","journal-title":"Nat Med"},{"key":"BFonc201067_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.leu.2404224","volume":"20","author":"S Giuntoli","year":"2006","unstructured":"Giuntoli S, Rovida E, Barbetti V, Cipolleschi MG, Olivotto M, Dello Sbarba P . (2006). Hypoxia suppresses BCR\/Abl and selects imatinib-insensitive progenitors within clonal CML populations. Leukemia 20: 1291\u20131293.","journal-title":"Leukemia"},{"key":"BFonc201067_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. (2001). Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293: 876\u2013880.","journal-title":"Science"},{"key":"BFonc201067_CR11","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","volume":"10","author":"S Gottschalk","year":"2004","unstructured":"Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ . (2004). Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res 10: 6661\u20136668.","journal-title":"Clin Cancer Res"},{"key":"BFonc201067_CR12","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1073\/pnas.0408283102","volume":"102","author":"K Gumireddy","year":"2005","unstructured":"Gumireddy K, Baker SJ, Cosenza SC, John P, Kang AD, Robell KA et al. (2005). A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proc Natl Acad Sci USA 102: 1992\u20131997.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201067_CR13","doi-asserted-by":"publisher","first-page":"H2228","DOI":"10.1152\/ajpheart.00615.2005","volume":"290","author":"SA Gupte","year":"2006","unstructured":"Gupte SA, Wolin MS . (2006). Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. Am J Physiol Heart Circ Physiol 290: H2228\u2013H2238.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFonc201067_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/pmic.200500182","volume":"6","author":"RF Haseloff","year":"2006","unstructured":"Haseloff RF, Krause E, Bigl M, Mikoteit K, Stanimirovic D, Blasig IE . (2006). Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 6: 1803\u20131809.","journal-title":"Proteomics"},{"key":"BFonc201067_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D et al. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311\u2013321.","journal-title":"Cancer Cell"},{"key":"BFonc201067_CR16","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC . (2003). Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23: 9361\u20139374.","journal-title":"Mol Cell Biol"},{"key":"BFonc201067_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1021\/bi00859a046","volume":"6","author":"J Katz","year":"1967","unstructured":"Katz J, Rognstad R . (1967). The labeling of pentose phosphate from glucose-14C and estimation of the rates of transaldolase, transketolase, the contribution of the pentose cycle, and ribose phosphate synthesis. Biochemistry 6: 2227\u20132247.","journal-title":"Biochemistry"},{"key":"BFonc201067_CR18","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/sj.leu.2402309","volume":"15","author":"K Keeshan","year":"2001","unstructured":"Keeshan K, Mills KI, Cotter TG, McKenna SL . (2001). Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 15: 1823\u20131833.","journal-title":"Leukemia"},{"key":"BFonc201067_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/sj.leu.2404137","volume":"20","author":"JS Khorashad","year":"2006","unstructured":"Khorashad JS, Anand M, Marin D, Saunders S, Al-Jabary T, Iqbal A et al. (2006). The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib. Leukemia 20: 658\u2013663.","journal-title":"Leukemia"},{"key":"BFonc201067_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim JW, Tchernyshyov I, Semenza GL, Dang CV . (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177\u2013185.","journal-title":"Cell Metab"},{"key":"BFonc201067_CR21","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","volume":"15","author":"DJ Kominsky","year":"2009","unstructured":"Kominsky DJ, Klawitter J, Brown JL, Boros LG, Melo JV, Eckhardt SG et al. (2009). Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Clin Cancer Res 15: 3442\u20133450.","journal-title":"Clin Cancer Res"},{"key":"BFonc201067_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s004320050175","volume":"124","author":"S Kress","year":"1998","unstructured":"Kress S, Stein A, Maurer P, Weber B, Reichert J, Buchmann A et al. (1998). Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 124: 315\u2013320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc201067_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1101\/gad.1529107","volume":"21","author":"JJ Lum","year":"2007","unstructured":"Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL et al. (2007). The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 21: 1037\u20131049.","journal-title":"Genes Dev"},{"key":"BFonc201067_CR24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","volume":"96","author":"FX Mahon","year":"2000","unstructured":"Mahon FX, Deininger MW, Schultheis B, Chabrol J, Reiffers J, Goldman JM et al. (2000). Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood 96: 1070\u20131079.","journal-title":"Blood"},{"key":"BFonc201067_CR25","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","volume":"100","author":"M Mayerhofer","year":"2002","unstructured":"Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C . (2002). BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 100: 3767\u20133775.","journal-title":"Blood"},{"key":"BFonc201067_CR26","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1182\/blood-2006-06-032490","volume":"109","author":"H Modi","year":"2007","unstructured":"Modi H, McDonald T, Chu S, Yee JK, Forman SJ, Bhatia R . (2007). Role of BCR\/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells. Blood 109: 5411\u20135421.","journal-title":"Blood"},{"key":"BFonc201067_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gde.2005.11.002","volume":"16","author":"T O'Hare","year":"2006","unstructured":"O'Hare T, Corbin AS, Druker BJ . (2006). Targeted CML therapy: controlling drug resistance, seeking cure. Curr Opin Genet Dev 16: 92\u201399.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc201067_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/MCB.01223-06","volume":"27","author":"Y Pan","year":"2007","unstructured":"Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ et al. (2007). Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 27: 912\u2013925.","journal-title":"Mol Cell Biol"},{"key":"BFonc201067_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC . (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187\u2013197.","journal-title":"Cell Metab"},{"key":"BFonc201067_CR30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.200512100","volume":"175","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS et al. (2006). Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175: 913\u2013923.","journal-title":"J Cell Biol"},{"key":"BFonc201067_CR31","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1172\/JCI31988","volume":"117","author":"DW Sherbenou","year":"2007","unstructured":"Sherbenou DW, Druker BJ . (2007). Applying the discovery of the Philadelphia chromosome. J Clin Invest 117: 2067\u20132074.","journal-title":"J Clin Invest"},{"key":"BFonc201067_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.exphem.2006.08.017","volume":"35","author":"JE Thompson","year":"2007","unstructured":"Thompson JE, Conlon JP, Yang X, Sanchez PV, Carroll M . (2007). Enhanced growth of myelodysplastic colonies in hypoxic conditions. Exp Hematol 35: 21\u201331.","journal-title":"Exp Hematol"},{"key":"BFonc201067_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0360-3016(92)90500-H","volume":"22","author":"SW Tuttle","year":"1992","unstructured":"Tuttle SW, Varnes ME, Mitchell JB, Biaglow JE . (1992). Sensitivity to chemical oxidants and radiation in CHO cell lines deficient in oxidative pentose cycle activity. Int J Radiat Oncol Biol Phys 22: 671\u2013675.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFonc201067_CR34","doi-asserted-by":"publisher","first-page":"36790","DOI":"10.1074\/jbc.M700327200","volume":"282","author":"SW Tuttle","year":"2007","unstructured":"Tuttle SW, Maity A, Oprysko PR, Kachur AV, Ayene IS, Biaglow JE et al. (2007). Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for the mechanism of HIF-1alpha stabilization under moderate hypoxia. J Biol Chem 282: 36790\u201336796.","journal-title":"J Biol Chem"},{"key":"BFonc201067_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1432-1033.1992.tb17420.x","volume":"210","author":"DW Zaharevitz","year":"1992","unstructured":"Zaharevitz DW, Anderson LW, Malinowski NM, Hyman R, Strong JM, Cysyk RL . (1992). Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivo. Eur J Biochem 210: 293\u2013296.","journal-title":"Eur J Biochem"},{"key":"BFonc201067_CR36","doi-asserted-by":"publisher","first-page":"10892","DOI":"10.1074\/jbc.M800102200","volume":"283","author":"H Zhang","year":"2008","unstructured":"Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB et al. (2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892\u201310903.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201067","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:34:03Z","timestamp":1647869643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,15]]},"references-count":36,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2010,5,20]]}},"alternative-id":["BFonc201067"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.67","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,15]]},"assertion":[{"value":"18 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}